Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Accuray Incorporated (ARAY) Guidance & Earnings Results

On 2025-11-05 Accuray Incorporated reaffirmed guidance: "FY2026 revenue $471M-$485M; Adjusted EBITDA…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

ARAYAccuray IncorporatedFollow ARAY — free
Medical Devices · Healthcare
—
Price chart with a free account
Market cap
15.5M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
4 Nov, in 11 days

What management guided

each earnings 8-K · figures checked against the filing text
ReleaseDirectionWhat they said
5 Nov 25ReaffirmedFY2026 revenue $471M-$485M; Adjusted EBITDA $31M-$35M · full year
20 Oct 25—Target high single-digit adjusted EBITDA margin run-rate within twelve months; double-digit over medium to long term.
13 Aug 25RaisedFY26 total net revenue $471M-$485M; FY26 adjusted EBITDA $31M-$35M · full year

Accuray Incorporated — questions

What guidance did Accuray Incorporated give?
On 2025-11-05: "FY2026 revenue $471M-$485M; Adjusted EBITDA $31M-$35M"
When does Accuray Incorporated report earnings?
Accuray Incorporated's next earnings report is expected on 2026-11-04.

Every figure on this page comes from Accuray Incorporated's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.